232 related articles for article (PubMed ID: 17457329)
1. Membranous nephropathy: when and how to treat.
Lai KN
Kidney Int; 2007 May; 71(9):841-3. PubMed ID: 17457329
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
du Buf-Vereijken PW; Branten AJ; Wetzels JF
Am J Kidney Dis; 2005 Dec; 46(6):1012-29. PubMed ID: 16310567
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic membranous nephropathy: new therapeutic trends.
Rostoker G
Eur J Med; 1993 Feb; 2(2):106-16. PubMed ID: 8258013
[No Abstract] [Full Text] [Related]
4. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic membranous nephropathy: diagnosis and treatment.
Fervenza FC; Sethi S; Specks U
Clin J Am Soc Nephrol; 2008 May; 3(3):905-19. PubMed ID: 18235148
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial.
Praga M; Barrio V; Juárez GF; Luño J;
Kidney Int; 2007 May; 71(9):924-30. PubMed ID: 17377504
[TBL] [Abstract][Full Text] [Related]
8. Membranous glomerulopathy associated with idiopathic hypereosinophilic syndrome.
Frigui M; Hmida MB; Jallouli M; Kechaou M; Frikha F; Bahloul Z
Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):320-2. PubMed ID: 20228521
[TBL] [Abstract][Full Text] [Related]
9. [Idiopathic membranous nephropathy associated with anti-calcineurin toxicity. Prognosis and other immunosuppressive treatments].
Muñoz Díaz AB; Aguilar P
Nefrologia; 2004; 24 Suppl 3():76-80. PubMed ID: 15219075
[TBL] [Abstract][Full Text] [Related]
10. [Treatment and prognosis of idiopathic membranous nephropathy in guidelines for nephrotic syndrome].
Saito T
Nihon Jinzo Gakkai Shi; 2011; 53(5):708-12. PubMed ID: 21842605
[No Abstract] [Full Text] [Related]
11. An overview of immunosuppressive therapy in idiopathic membranous nephropathy.
Maas R; Hofstra JM; Wetzels JF
Minerva Med; 2012 Aug; 103(4):253-66. PubMed ID: 22805618
[TBL] [Abstract][Full Text] [Related]
12. [Membranous kidney diseases in adults].
Sobarzo Toro M; Vilches A
Medicina (B Aires); 2004; 64(1):59-65. PubMed ID: 15034960
[TBL] [Abstract][Full Text] [Related]
13. Treatment of idiopathic membranous nephropathy (IMN).
Alexopoulos E; Papagianni A
Ren Fail; 2000 Nov; 22(6):697-709. PubMed ID: 11104159
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy.
McQuarrie EP; Stirling CM; Geddes CC
Nephrol Dial Transplant; 2012 Jan; 27(1):235-42. PubMed ID: 21558430
[TBL] [Abstract][Full Text] [Related]
15. [The pharmacotherapy of chronic glomerulonephritis].
Ratner MIa; Biriukova LS
Klin Med (Mosk); 1992 Jan; 70(1):114-9. PubMed ID: 1608196
[No Abstract] [Full Text] [Related]
16. Treatment of membranous nephropathy.
Ponticelli C; Passerini P
Nephrol Dial Transplant; 2001; 16 Suppl 5():8-10. PubMed ID: 11509678
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study.
Naumovic R; Jovanovic D; Pavlovic S; Stosovic M; Marinkovic J; Basta-Jovanovic G
Biomed Pharmacother; 2011 Mar; 65(2):105-10. PubMed ID: 21109389
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine treatment of glomerular diseases.
Klein M; Radhakrishnan J; Appel G
Annu Rev Med; 1999; 50():1-15. PubMed ID: 10073260
[TBL] [Abstract][Full Text] [Related]
19. Benefit and cost from the long-term use of cyclosporine-A in idiopathic membranous nephropathy.
Kalliakmani P; Koutroulia E; Sotsiou F; Vlachojannis JG; Goumenos DS
Nephrology (Carlton); 2010 Dec; 15(8):762-7. PubMed ID: 21175962
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of idiopathic membranous nephropathy].
Passerini P
G Ital Nefrol; 2004; 21(6):531-9. PubMed ID: 15593020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
